FGEN — Fibrogen Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual income statement for Fibrogen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	C2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	176	235	141	46.8	29.6
Cost of Revenue
Gross Profit	167	222	120	42.8	14.1
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	368	524	442	370	180
Operating Profit	-192	-289	-301	-323	-150
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-189	-291	-295	-323	-153
Provision for Income Taxes
Net Income After Taxes	-189	-291	-295	-323	-153
Equity in Affiliates
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-189	-290	-294	-284	-47.6
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-189	-290	-294	-284	-47.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-2.11	-3.14	-3.14	-3.24	-1.4